drugset / Trial / NCT05147805
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The main objective of the study is to assess the effect of treprostinil palmitil inhalation powder (TPIP) compared with placebo on pulmonary vascular resistance.
Timeline
- Start
- 2022-08-24
- Primary completion
- 2025-03-27
- Completion
- 2025-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil Palmitil | Small molecule | 80 ug | Inhaled |
| Subject | Treprostinil Palmitil | Small molecule | 640 ug | Inhaled |